RE: Blue day incoming18 Jul 2024 11:13
Did the share price here fall to far?
Revenue from company has mostly come from food sensitivity tests for years.
Losses from other parts of company have eaten away at that revenue. Those parts of compang have been sold and raised millions of pounds, and also stopping this losses.
Warrants talk was around for months depressing the shareprice, warrants expired and consultants were brought in to increase productivity.
Results in Trading Update were ahead of market expectations, and full results are to be teased in 5 working days time. Further updates from numerous things microbiome test, nutrigenomic test, gov dispute, counterclaim, future outlook, hopefully will be included. Gross profit was to exceed £6m up from £3.5m,losses had been reduced further, further improvements made,and further improvements identified and to be implemented. Roughly work out, there's no £500,000 relocation costs to be deducted like kat year, or the one off payments for the microbiome and nutrigenomic tests. I think that was £300,000.
Calculators working yet?